Kurser indlæses...
Prognose
Analytikernes gennemsnitlige kursmål er 427,66 € (+7,32 %). Medianen er 435,30 € (+9,23 %).
| Køb |
27 |
| Behold |
11 |
| Sælg |
0 |
Diskussioner i communityet
Der er endnu ingen diskussion om dette aktiv.
Start diskussionNyheder Til nyhedsfeedet
Elevance Health boosts revenue and earnings in quarter ended Sept. 30, 2026
For the quarter ended Sept. 30, 2026, Elevance Health reported earnings per share of USD 6.27 compared with USD 5.32 in the prior-year quarter. Revenue rose 1.42 percent to USD 51.43 billion (prior year: USD 50.71 billion). » Mere på finanzen.net
Elevance Health confirms annual guidance and signals positive Q3, shares rise
Elevance Health’s stock jumped about 5.8% intraday after a regulatory filing in which the company confirmed its adjusted earnings guidance for 2026 of at least $27.00 per share. At the Wells Fargo healthcare conference, Elevance said adjusted EPS for Q3 is above the guidance it gave after Q2; it also reaffirmed an operating cash-flow target of at least $6 billion for 2026 and a 2027 target of at least 12% adjusted EPS growth versus 2026. Today’s ex-dividend date (dividend $1.72 per share) may have prompted additional buying interest. » Mere på de.investing.com
Elevance Health confirms 2026 EPS target and leans on Carelon growth for margin protection
Elevance Health confirms an adjusted EPS target of at least $27.00 for 2026 despite significant one-off items. The company is realizing substantial synergies through the rapid expansion of its profitable services arm, Carelon. CEO Gail Boudreaux prioritizes margin protection and is deliberately forgoing unprofitable member growth. The operating model remains a combination of a traditional insurance business and a high-growth services segment. » Mere på finanzen.net
Elevance Health raises full-year EPS outlook after Q2 profit of $1.45 billion
Elevance Health reported second-quarter net income of $1.45 billion ($6.71 per share), a year-over-year decline, as its benefit expense ratio rose to 89.7% due to elevated medical costs in government businesses. Revenue grew 1.4% to $50.47 billion and membership fell to 44.9 million. Strong operating performance and favorable benefit expense trends prompted the company to raise 2026 adjusted EPS guidance to at least $27.00 and its full-year EPS outlook to at least $20.10 per share. Management highlighted disciplined execution, improved individual ACA results, and increased investment in medical cost management and Carelon services. » Mere på forbes.com
Margin pressure at Elevance Health cuts margins and sends insurer shares tumbling
Elevance Health reported Q2 2026 revenue rising to $50.47 billion and adjusted EPS of $7.45, but the operating margin in its Health Benefits segment fell from 5.0% to 3.6%. The stock lost 6.7% in premarket trading after it emerged the result was supported by a one‑off item of $0.80 per share and the core business is under significant pressure. Operating income in the Health Benefits segment nearly halved, membership slipped slightly to 44.95 million, and analysts expect declining revenues. Margin concerns also weighed on shares across the industry, including UnitedHealth, Molina, Humana, Centene and CVS. » Mere på de.investing.com
Historisk udbytte Udbytte
Alle nøgletal for udbytte Alle nøgletalVirksomhedstal
| (EUR) | september 2026 | YoY |
|---|---|---|
| Omsætning | 45,4 mia. | 5,07 % |
| Bruttofortjeneste | 7,07 mia. | 33,98 % |
| Nettoresultat | 1,21 mia. | 18,94 % |
| EBITDA | 2,22 mia. | 21,53 % |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 84,45 mia. € |
Antal aktier | 216,06 mio. |
Højeste/laveste i 52 uger | 410,00 € - 250,02 € |
Udbytteafkast | 1,46 % |
Udbytte TTM | 5,97 € |
Beta | 0,71 |
P/E (PE Ratio) | 18,30 |
PEG (PEG Ratio) | -4,31 |
K/I (PB Ratio) | 2,09 |
P/S (PS Ratio) | 0,46 |
Virksomhedsprofil
Anthem, Inc. opererer gennem sine datterselskaber som et selskab inden for sundhedsydelser i USA. Selskabet er organiseret i fire segmenter: Commercial & Specialty Business, Government Business, IngenioRx og Other. Selskabet tilbyder et spektrum af netværksbaserede managed care-sundhedsydelsesplaner til store og små grupper, privatpersoner, Medicaid- og Medicare-markederne. Dets managed care-planer omfatter preferred provider organizations; health maintenance organizations; point-of-service-planer; traditionelle skadesløsesplaner og andre hybridplaner, herunder forbrugerdrevne sundhedsplaner; samt hospital only- og begrænsede ydelsesprodukter. Selskabet leverer også en række managed care-tjenester til selvfinansierede kunder, herunder sagsbehandling af skadesanmeldelser, risikovurdering, stop loss-forsikring, aktuarydelser, adgang til leverandørnetværk, medicinsk styring, sygdomsstyring, wellnessprogrammer og andre administrative ydelser. Derudover tilbyder det et udvalg af specialiserede og andre forsikringsprodukter og -ydelser, såsom farmaceutisk ydelsesadministration (pharmacy benefits management), tand-, syn-, livs- og invaliditetsforsikringsydelser samt analysedrevet personlig sundhedspleje. Desuden leverer selskabet ydelser til den amerikanske regering i forbindelse med Federal Employee Program og driver som licenstager for Blue Cross and Blue Shield Association. Pr. 31. december 2021 betjente det 45 millioner medicinske medlemmer gennem sine tilknyttede sundhedsplaner. Selskabet var tidligere kendt som WellPoint, Inc. og skiftede navn til Anthem, Inc. i december 2014. Anthem, Inc. blev grundlagt i 1944 og har hovedsæde i Indianapolis, Indiana.
| Navn | Elevance Health Inc. |
| CEO | Gail Koziara Boudreaux |
| Hjemsted | Indianapolis,
in USA |
| Websted | |
| Sektor | Sundhed |
| Branche | Sundhedsudbydere og -tjenester |
| Børsnotering | 30.10.2001 |
| Medarbejdere | 96.615 |
Tickersymboler
| Børs | Symbol |
|---|---|
NYSE | ELV |
London Stock Exchange | 0HG8.L |
NYSE | ANTM |
Frankfurt | A58.F |
Düsseldorf | A58.DU |
Milan | 1ANTM.MI |
London | 0HG8.L |
SIX | A58.SW |
München | A58.MU |
Wien | ANTM.VI |